Appropriate reflux management in pharmacy

Management strategies for reflux begin with lifestyle and diet modifications, and if symptoms persist, non-prescription medicines may be recommended.

PBS changes for prescription opioids

Changes to regulations on opioid supply in Australia came into effect this week, with new Pharmaceutical Benefits Scheme listings resulting in smaller quantities and restrictions around opioid prescribing for pain treatment.

Gout management: treat to target

Gout and hyperuricaemia are major health issues as they are associated with metabolic syndrome, diabetes mellitus, obesity and hypertension.

Triptans downscheduled to S3 medicines

Last year, the Therapeutic Goods Administration announced that certain triptans will be available over the counter in 2021.

COVID-19 and influenza vaccinations: tips for community pharmacists

The COVID-19 pandemic makes it more important than ever for Australians to access influenza vaccinations and pharmacist immunisers are ready to help protect the community.

New Label 24 to help pharmacists reduce opioid risks

In line with TGA regulatory changes to enhance medicine safety, PSA has developed a cautionary advisory label that warns consumers about the risk of opioid overdose and dependence.